While the battle rages on about the endogenous repair capacity in the heart, solid work is progressing to take the promising exogenous pluripotent stem cells toward a clinical application. Sian Harding is Professor of Cardiac Pharmacology at the National Heart and Lung Institute, Imperial College, as well as Institute Lead for Women for Athena Swan, and a co-investigator within the UKRMP Immunomodulation Hub.